Israeli firm Inovytec Medical Solutions revealed on Monday that it received a $3 million investment from China's Vincent Medical Holdings for a 15 percent stake in the company.

The recent investment will pave way for Inovytec to enter the Chinese market. The company develops and markets emergency medicine and trauma care products used for out-of-hospital situations that aim to help even non-trained health personnel offer life-saving emergency responses to patients.

Like Us on Facebook

Inovytec will be able to "capitalize on the huge potential that exists in China and in the area in the sector of medical devices," Udi Cantor, CEO and founder of the startup firm, said.

The portable medical device maker's LUBO product has already gained CE and FDA approval. The item is designed to facilitate neck braces and allow the opening of the airway in a noninvasive manner.

It has also developed the SALI, a device that could treat both cardiac and respiratory failures. It permits emergency responders to manage airways, oxygen therapy, and defibrillation on the spot, while sending signals and data to a nearby emergency center via cloud technology.

Vincent Medical, on the other hand, said that the Chinese firm is "committed to support innovative products and identify relevant opportunities around the world, to increase the scope of products it offers," Vincent Choi, the company's founder said, noting that the recent strategic move will help the firm expand its portfolio on products necessary during emergency care.

The new investment allowed Inovytec to achieve its target for its first capital-raising round. The company raised several million dollars last November after another strategic investment with German firm Rhon Klinikum.

"The completion of the capital raising round reflects the confidence key medical players in Europe and Asia have in Inovytec. It allows us to focus on accelerating sales and complete the development and regulatory certification of products in our pipeline," Ralph Sassun, Inovytec's CFO, said.